When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?

AMA J Ethics. 2024 Jul 1;26(7):E520-526. doi: 10.1001/amajethics.2024.520.

Abstract

Structural and systemic discrimination against people with substance use disorder is pervasive. Clinicians caring for patients receiving medications for opioid use disorders (MOUDs) should plan for possible disruptions of treatment caused by arrests and pretrial confinement in jails. This case commentary suggests that harms caused by such treatment disruption can be mitigated by clinicians who take some of the practical approaches outlined in this commentary to better preserve continuity of care for people receiving MOUD.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Analgesics, Opioid / adverse effects
  • Analgesics, Opioid / therapeutic use
  • Buprenorphine / therapeutic use
  • Continuity of Patient Care
  • Humans
  • Male
  • Opiate Substitution Treatment*
  • Opioid-Related Disorders* / drug therapy

Substances

  • Analgesics, Opioid
  • Buprenorphine